NDC 51655-915 – Terazosin
Terazosin Hydrochloride 2 mg/1 · Capsule · Oral
Product NDC51655-915
Product details
- Brand name
- Terazosin
- Generic name
- Terazosin
- Labeler
- Northwind Health Company, LLC
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA075614
- Marketed since
- June 26, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- alpha-Adrenergic Blocker
Active ingredients
- Terazosin Hydrochloride 2 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 51655-915-52 | 30 CAPSULE in 1 BOTTLE, PLASTIC (51655-915-52) | Jun 26, 2023 |
Other Terazosin products
- 50090-2623 Terazosin Hydrochloride 2 mg/1 · Capsule · A-S Medication Solutions
- 50090-7851 Terazosin Hydrochloride 1 mg/1 · Capsule · A-S Medication Solutions
- 50090-2371 Terazosin Hydrochloride 10 mg/1 · Capsule · A-S Medication Solutions
- 50090-1559 Terazosin Hydrochloride 5 mg/1 · Capsule · A-S Medication Solutions
- 50090-0657 Terazosin Hydrochloride 1 mg/1 · Capsule · A-S Medication Solutions
- 27241-288 Terazosin Hydrochloride 1 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 27241-289 Terazosin Hydrochloride 2 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 27241-290 Terazosin Hydrochloride 5 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 27241-291 Terazosin Hydrochloride 10 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 53401-022 Terazosin Hydrochloride 1 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC
- 71610-503 Terazosin Hydrochloride 5 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC
- 71610-478 Terazosin Hydrochloride 1 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC